Alterity Therapeutics Statistics
Total Valuation
ATHE has a market cap or net worth of $45.60 million. The enterprise value is $19.55 million.
| Market Cap | 45.60M |
| Enterprise Value | 19.55M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATHE has 218.50 million shares outstanding. The number of shares has increased by 64.53% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 218.50M |
| Shares Change (YoY) | +64.53% |
| Shares Change (QoQ) | +6.78% |
| Owned by Insiders (%) | 3.06% |
| Owned by Institutions (%) | 32.82% |
| Float | 181.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.45 |
| Forward PS | 61.87 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.52 |
| Quick Ratio | 14.26 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.98% and return on invested capital (ROIC) is -36.70%.
| Return on Equity (ROE) | -54.98% |
| Return on Assets (ROA) | -34.08% |
| Return on Invested Capital (ROIC) | -36.70% |
| Return on Capital Employed (ROCE) | -58.54% |
| Weighted Average Cost of Capital (WACC) | 4.21% |
| Revenue Per Employee | $227,038 |
| Profits Per Employee | -$1.47M |
| Employee Count | 11 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATHE has paid $78,519 in taxes.
| Income Tax | 78,519 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.33% in the last 52 weeks. The beta is -0.01, so ATHE's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -41.33% |
| 50-Day Moving Average | 3.40 |
| 200-Day Moving Average | 3.97 |
| Relative Strength Index (RSI) | 41.88 |
| Average Volume (20 Days) | 223,589 |
Short Selling Information
The latest short interest is 38,516, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 38,516 |
| Short Previous Month | 26,107 |
| Short % of Shares Out | 0.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.73 |
Income Statement
In the last 12 months, ATHE had revenue of $2.50 million and -$16.19 million in losses. Loss per share was -$0.93.
| Revenue | 2.50M |
| Gross Profit | 2.32M |
| Operating Income | -17.36M |
| Pretax Income | -16.11M |
| Net Income | -16.19M |
| EBITDA | -17.36M |
| EBIT | -17.36M |
| Loss Per Share | -$0.93 |
Balance Sheet
The company has $25.82 million in cash and $133,840 in debt, with a net cash position of $25.68 million or $0.12 per share.
| Cash & Cash Equivalents | 25.82M |
| Total Debt | 133,840 |
| Net Cash | 25.68M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 29.56M |
| Book Value Per Share | 0.14 |
| Working Capital | 29.52M |
Cash Flow
In the last 12 months, operating cash flow was -$15.74 million and capital expenditures -$5,592, giving a free cash flow of -$15.74 million.
| Operating Cash Flow | -15.74M |
| Capital Expenditures | -5,592 |
| Depreciation & Amortization | 2,479 |
| Net Borrowing | -95,459 |
| Free Cash Flow | -15.74M |
| FCF Per Share | -$0.07 |
Margins
| Gross Margin | 92.72% |
| Operating Margin | -695.13% |
| Pretax Margin | -645.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATHE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -64.53% |
| Shareholder Yield | -64.53% |
| Earnings Yield | -37.75% |
| FCF Yield | -40.81% |
Analyst Forecast
The average price target for ATHE is $13.25, which is 436.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.25 |
| Price Target Difference | 436.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -14.18% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 9, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ATHE has an Altman Z-Score of 11 and a Piotroski F-Score of 2.
| Altman Z-Score | 11 |
| Piotroski F-Score | 2 |